Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pediatric Cancers
Vaccine Research Results Show Hope For Use Of Dendritic Cells
April 11th, 2001
Results from the first-ever study testing the use of dendritic cells in children may offer new hope for a cancer vaccine. The Phase I study results from research at the University of Michigan Health System were presented March 27, 2001, by James D. Geiger, MD, UMHS assistant professor of surgery and the study's principal investigator, at the annual meeting of the American Association for Cancer Research. The research suggests that dendritic cells spiked with cancer proteins from a pediatric patient's own tumor can generate an immune response to the cancer, and may spark stabilization or regression of metastatic, or spreading, cancers. One of the...
Source: Vaccine Weekly (2001-04-11)
|
